Trial · NCT06083675
Registered outcomes45
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 45
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in glycated haemoglobin (HbA1c) | From randomisation (week 0) to week 52 | Measured in Percentage (%)-points. |
| Secondary | Change in body weight | From randomisation (week 0) to week 52 | Measured in kilograms (kg). |
| Secondary | Change in fasting plasma glucose (FPG) | From randomisation (week 0) to week 52 | Measured in millimoles per liter (mmol/L). |
| Secondary | Change in 7 point self measured plasma glucose (SMPG) mean profile | From randomisation (week 0) to week 52 | Measured in mmol/L. |
| Secondary | Change in 7-point self-measured plasma glucose (SMPG) mean post prandial increments | From randomisation (week 0) to week 52 | Measured in mmol/L. |
| Secondary | Relative change in body weight | From randomisation (week 0) to week 52 | Measured in Percentage (%). |
| Secondary | Change in waist circumference | From randomisation (week 0) to week 52 | Measured in centimeters (cm). |
| Secondary | HbA1c less than or equal to (≤) 6.5% (Yes/No) | At week 52 | Measured as count of participants. |
| Secondary | HbA1c less than (<) 7% (Yes/No) | At week 52 | Measured as count of participants. |
| Secondary | Body weight reduction greater than equal to ( ≥) 5% (Yes/No) | At week 52 | Measured as count of participants. |
| Secondary | Body weight reduction ≥10% (Yes/No) | At week 52 | Measured as count of participants. |
| Secondary | Body weight reduction ≥15% (Yes/No) | At week 52 | Measured as count of participants. |
| Secondary | HbA1c <7.0% and body weight reduction ≥5% (Yes/No) | At week 52 | Measured as count of participants. |
| Secondary | Change in systolic blood pressure | From randomisation (week 0) to week 52 | Measured in millimeters of mercury (mmHg). |
| Secondary | Change in diastolic blood pressure | From randomisation (week 0) to week 52 | Measured in mmHg. |
| Secondary | Change in High-sensitivity C-reactive protein (hsCRP) | From randomisation (week 0) to week 52 | Measured in milligrams per liter (mg/L). |
| Secondary | Time to rescue medication | From randomisation (week 0) to week 104 | Measured in days. |
| Secondary | Change in HbA1c | From randomisation (week 0) to week 104 | Measured in %-points. |
| Secondary | Change in body weight | From randomisation (week 0) to week 104 | Measured in kg. |
| Secondary | Change in FPG | From randomisation (week 0) to week 104 | Measured in mmol/L. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06083675/registered